» Articles » PMID: 22590612

Ischemia-reperfusion Injury and Pregnancy Initiate Time-dependent and Robust Signs of Up-regulation of Cardiac Progenitor Cells

Abstract

To explore how cardiac regeneration and cell turnover adapts to disease, different forms of stress were studied for their effects on the cardiac progenitor cell markers c-Kit and Isl1, the early cardiomyocyte marker Nkx2.5, and mast cells. Adult female rats were examined during pregnancy, after myocardial infarction and ischemia-reperfusion injury with/out insulin like growth factor-1(IGF-1) and hepatocyte growth factor (HGF). Different cardiac sub-domains were analyzed at one and two weeks post-intervention, both at the mRNA and protein levels. While pregnancy and myocardial infarction up-regulated Nkx2.5 and c-Kit (adjusted for mast cell activation), ischemia-reperfusion injury induced the strongest up-regulation which occurred globally throughout the entire heart and not just around the site of injury. This response seems to be partly mediated by increased endogenous production of IGF-1 and HGF. Contrary to c-Kit, Isl1 was not up-regulated by pregnancy or myocardial infarction while ischemia-reperfusion injury induced not a global but a focal up-regulation in the outflow tract and also in the peri-ischemic region, correlating with the up-regulation of endogenous IGF-1. The addition of IGF-1 and HGF did boost the endogenous expression of IGF and HGF correlating to focal up-regulation of Isl1. c-Kit expression was not further influenced by the exogenous growth factors. This indicates that there is a spatial mismatch between on one hand c-Kit and Nkx2.5 expression and on the other hand Isl1 expression. In conclusion, ischemia-reperfusion injury was the strongest stimulus with both global and focal cardiomyocyte progenitor cell marker up-regulations, correlating to the endogenous up-regulation of the growth factors IGF-1 and HGF. Also pregnancy induced a general up-regulation of c-Kit and early Nkx2.5+ cardiomyocytes throughout the heart. Utilization of these pathways could provide new strategies for the treatment of cardiac disease.

Citing Articles

Pretreatment with geniposide mitigates myocardial ischemia/reperfusion injury by modulating inflammatory response through TLR4/NF-κB pathway.

Yao Y, Lin L, Tang W, Shen Y, Chen F, Li N Eur J Histochem. 2023; 67(3).

PMID: 37682077 PMC: 10518652. DOI: 10.4081/ejh.2023.3742.


Conversion of α-Cells to β-Cells in the Postpartum Mouse Pancreas Involves Lgr5 Progeny.

Rodriguez U, Socorro M, Criscimanna A, Martins C, Mohamed N, Hu J Diabetes. 2021; 70(7):1508-1518.

PMID: 33906911 PMC: 8336010. DOI: 10.2337/db20-1059.


The Atrioventricular Junction: A Potential Niche Region for Progenitor Cells in the Adult Human Heart.

Vukusic K, Sandstedt M, Jonsson M, Jansson M, Oldfors A, Jeppsson A Stem Cells Dev. 2019; 28(16):1078-1088.

PMID: 31146637 PMC: 6686725. DOI: 10.1089/scd.2019.0075.


Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions.

Bestall S, Hulse R, Blackley Z, Swift M, Ved N, Paton K J Cell Sci. 2018; 131(14).

PMID: 29930087 PMC: 6080605. DOI: 10.1242/jcs.215939.


Cardiac Progenitor Cells and the Interplay with Their Microenvironment.

Mauretti A, Spaans S, Bax N, Sahlgren C, Bouten C Stem Cells Int. 2017; 2017:7471582.

PMID: 29075298 PMC: 5623801. DOI: 10.1155/2017/7471582.


References
1.
Martin C, Meeson A, Robertson S, Hawke T, Richardson J, Bates S . Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol. 2003; 265(1):262-75. DOI: 10.1016/j.ydbio.2003.09.028. View

2.
Winer J, Jung C, Shackel I, Williams P . Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999; 270(1):41-9. DOI: 10.1006/abio.1999.4085. View

3.
Torella D, Ellison G, Mendez-Ferrer S, Ibanez B, Nadal-Ginard B . Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med. 2006; 3 Suppl 1:S8-13. DOI: 10.1038/ncpcardio0409. View

4.
Hsieh P, Segers V, Davis M, Macgillivray C, Gannon J, Molkentin J . Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007; 13(8):970-4. PMC: 2754571. DOI: 10.1038/nm1618. View

5.
Wang Y, Ahmad N, Wani M, Ashraf M . Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol. 2004; 37(5):1041-52. DOI: 10.1016/j.yjmcc.2004.09.004. View